Gates Foundation donates $150 million to push coronavirus vaccine doses below $3

The Bill & Melinda Gates Foundation is trying to make sure an eventual coronavirus vaccine is affordable for everyone.

[Aug. 7, 2020: The Week]

The Bill & Melinda Gates Foundation is trying to make sure an eventual coronavirus vaccine is affordable for everyone.

The foundation has donated $150 million to the Serum Institute of India, the world's largest vaccine maker, the Gavi vaccine alliance announced Friday. The money will help speed up the development and distribution of an eventual COVID-19 vaccine and make it available to 92 poorer countries for no more than $3 per dose.


Like these kind of stories? Get The Brighter Side of News' newsletter.


"Too many times we've seen the most vulnerable countries left at the back of the queue when it comes to new treatments, new diagnostics and new vaccines," said Gavi CEO Dr. Seth Berkley. But the consequences of such inequities when distributing a COVID-19 vaccine would be devastating. "If only the wealthiest countries in the world are protected, then international trade, commerce and society as a whole will continue to be hit hard as the pandemic continues to rage across the globe," Berkley continued.

The Serum Institute of India is one of several manufacturers working with AstraZeneca to make its candidate vaccine. It's also the go-to supplier for the World Health Organization, The Wall Street Journal notes. A total of 92 countries will be eligible to receive the discount vaccine as Gavi seeks $2 billion total to further support vaccine access..... Read More



Joseph Shavit
Joseph ShavitSpace, Technology and Medical News Writer
Joseph Shavit is the head science news writer with a passion for communicating complex scientific discoveries to a broad audience. With a strong background in both science, business, product management, media leadership and entrepreneurship, Joseph possesses the unique ability to bridge the gap between business and technology, making intricate scientific concepts accessible and engaging to readers of all backgrounds.